Login / Signup

Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey.

Aziz KaracaMustafa Nuri GuncikanNazlı Nadire SozmenGizem Gokce KaradagMustafa YilmazKerem KinikFatma Meric Yilmaz
Published in: Medeniyet medical journal (2021)
An antibody response to SARS-CoV-2 was noted in a CP donor on the 244th day. The average IgG ratios were higher in the CP donors with the AB blood group, but lower in the O blood group. These results may be considered a valuable indication of the effectiveness of CP therapy used for the treatment of COVID-19 patients with clinically relevant blood types.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • randomized controlled trial
  • mesenchymal stem cells
  • cross sectional
  • bone marrow
  • smoking cessation